Submitted by Anonymous (not verified) on 2 September 2025 - 15:55
Human medicines European public assessment report (EPAR): Caelyx pegylated liposomal, doxorubicin, Date of authorisation: 20/06/1996, Revision: 38, Status: Authorised
Source: